Vor Biopharma VOR Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Vor Biopharma in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The official record: Vor Biopharma’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vor Biopharma's total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vor Biopharma's total equity?
- Vor Biopharma (VOR) reported total equity of -$150.42M in Q1 2026.
- How has Vor Biopharma's total equity changed year-over-year?
- Vor Biopharma's total equity decreased by 327.7% year-over-year, from $66.07M to -$150.42M.
- What is the long-term trend for Vor Biopharma's total equity?
- Over 5 years (2020 to 2025), Vor Biopharma's total equity has grown at a 22.7% compound annual growth rate (CAGR), from -$59.07M to -$164.31M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.